Dr Reddys Laboratories (RDY) Total Current Liabilities (2012 - 2026)

Dr Reddys Laboratories' Total Current Liabilities history runs 14 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 21.73% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (up 21.73% YoY), while the FY2026 annual figure was $1.8 billion, up 17.03% from the prior year.
• Total Current Liabilities was $1.8 billion for Q1 2026 at Dr Reddys Laboratories, up from $1.7 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $1.8 billion in Q1 2026 to a low of $20.0 million in Q1 2023.
• Historically, Total Current Liabilities has averaged $968.2 million across 5 years, with a median of $1.0 billion in 2023.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities slumped 43.56% in 2022, then soared 4796.16% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $1.0 billion in 2022, then gained by 1.45% to $1.0 billion in 2023, then jumped by 51.59% to $1.5 billion in 2024, then advanced by 12.09% to $1.7 billion in 2025, then rose by 5.93% to $1.8 billion in 2026.
• The last three Total Current Liabilities figures came in at $1.8 billion (Q1 2026), $1.7 billion (Q3 2025), and $1.5 billion (Q1 2025), per Business Quant data.